Everolimus

Back to search

Molecule Structure

Scientific Name

Everolimus

Description of the Drug

Everolimus is a mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01590

Brand Name(s)

Afinitor, Afinitor disperz, Certican, Votubia, Zortress

Company Owner(s)

Mylan Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc, Par Pharmaceutical, Novartis Pharmaceutical Corp, Novartis Pharmaceuticals Corp, Biocon Pharma Ltd, Breckenridge Pharmaceutical Inc, Teva Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
FK506-binding protein 1A SINGLE PROTEIN INHIBITOR CHEMBL1902

Unichem Links

Atlas RAD001
SureChEMBL SCHEMBL20973097 SCHEMBL4378
PharmGKB PA164746311
DrugBank DB01590
PubChem: Thomson Pharma 14767667 14865574
PubChem 6442177
LINCS LSM-43172
EPA CompTox Dashboard DTXSID0040599
DrugCentral 1118
ChemicalBook CB9502411
Guide to Pharmacology 5889
GSRS c3be78ca-34b3-40df-8932-b66dab64bc69
rxnorm ZORTRESS AFINITOR EVEROLIMUS
PubChem: Drugs of the Future 12014881
ChEBI 68478
ZINC ZINC000169677008